I just spoke with TK and he told me that Medgate need more time for workflow efficiencies. In other words making sure all the doctors understand and are confident with our AI and can confidently proceed with pathways if it gives a diagnosis of a respiratory infection. Tony pointed out that Medgate is the first Telehealth company in the world to use our AI and many doctors have to become confident in its usage.
So there is nothing suspicious about the announcement so everyone take some deep breaths. I also asked about The US COVID trials and he said all proceeding well. What else would he say?
- Forums
- ASX - By Stock
- RAP
- Ann: Medgate extends European ResAppDx trial
Ann: Medgate extends European ResAppDx trial, page-7
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 78 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online